New Animal Drugs for Use in Animal Feeds; Ractopamine; Monensin
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The NADA provides for use of single-ingredient Type A medicated articles containing ractopamine hydrochloride and monensin to formulate two-way combination Type C medicated feeds for finishing hen and tom turkeys.
Table of Contents Back to Top
DATES: Back to Top
This rule is effective February 5, 2010.
FOR FURTHER INFORMATION CONTACT: Back to Top
Linda M. Wilmot, Center for Veterinary Medicine (HFV-120), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8101, e-mail: email@example.com.
SUPPLEMENTARY INFORMATION: Back to Top
Elanco Animal Health, A Division of Eli Lilly Co., Lilly Corporate Center, Indianapolis, IN 46285, filed NADA 141-301 for use of TOPMAX (ractopamine hydrochloride) and COBAN (monensin, USP) single-ingredient Type A medicated articles to formulate two-way combination Type C medicated feeds for finishing hen and tom turkeys. The NADA is approved as of December 11, 2009, and the regulations in 21 CFR 558.500 are amended to reflect the approval.
In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33 that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:
PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS Back to Top
1.The authority citation for 21 CFR part 558 continues to read as follows:
2.In § 558.500, add paragraphs (e)(3)(iii) and (e)(3)(iv) to read as follows:
§ 558.500 Ractopamine.
(e) * * *
(3) * * *
|Ractopamine in grams/ton||Combination in grams/ton||Indications for use||Limitations||Sponsor|
|(iii) 4.6 to 11.8 (5 to 13 ppm)||Monensin 54 to 90||Finishing hen turkeys: As in paragraph (e)(3)(i) of this section; and for the prevention of coccidiosis in growing turkeys caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis.||Feed continuously as sole ration during the last 7 to 14 days prior to slaughter. See § 558.355(d).||000986|
|(iv) 4.6 to 11.8 (5 to 13 ppm)||Monensin 54 to 90||Finishing tom turkeys: As in paragraph (e)(3)(ii) of this section; and for the prevention of coccidiosis in growing turkeys caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis.||Feed continuously as sole ration during the last 14 days prior to slaughter. Feeding ractopamine to tom turkeys during periods of excessive heat can result in increased mortality. See § 558.355(d).||000986|
Dated: February 1, 2010.
Director, Center for Veterinary Medicine.
[FR Doc. 2010-2427 Filed 2-4-10; 8:45 am]
BILLING CODE 4160-01-S